PT - JOURNAL ARTICLE AU - Dave Chapman AU - Veronique Poirier AU - Karen Fitzgerald AU - Brian D. Nicholson AU - William Hamilton TI - Describing the potential of non-specific symptoms-based pathways for diagnosing less common cancers AID - 10.3399/BJGP.2020.1108 DP - 2021 Jun 01 TA - British Journal of General Practice PG - BJGP.2020.1108 4099 - http://bjgp.org/content/early/2021/06/09/BJGP.2020.1108.short 4100 - http://bjgp.org/content/early/2021/06/09/BJGP.2020.1108.full AB - Background: Although less common cancers account for over half of all cancer diagnoses in England, their relative scarcity and complex presentation, often with non-specific symptoms, means that patients often experience multiple primary care consultations, longer times to diagnosis and poorer clinical outcomes. An urgent referral pathway for non-specific symptoms, the Multidisciplinary Diagnostic Centre (MDC), may address this problem. Aim: To examine the less common cancers identified during the MDC pilots and consider if such an approach improves the diagnosis of these cancers. Design and Setting: A service evaluation of five MDC pilot projects in England to 31st March 2019. Method: Data items were collected by pilot sites in near-real time, based mainly on the English cancer outcomes and services dataset, with additional project specific items. Simple descriptive and comparative statistics were used, including chi-squared tests for proportions and t-tests for means where appropriate. Results: From 5,134 referrals, 378 cancers were diagnosed, of which 218 (58%) were less common. Over 30 different less common tumour types were diagnosed within this cohort. 23% of MDC patients with less common cancers had ≥3 more GP consultations before referral and, at programme level, a median time of 57 days was recorded from GP urgent referral to treatment for these tumour types. Conclusion: A non-specific symptomatic referral route diagnoses a broad range of less common cancers, and can support primary care case management for patients with symptoms of possible cancer that do not qualify for a site-specific urgent referral.